Beixing Liu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Beixing Liu has a total of 56 co-authors. Here are the top co-authors by number of shared publications:
Feifei Qi
Department of Immunology, School of Basic Medical Science, China Medical University, Shenyang, China
8 shared publicationsJia Wang
Department of Pathogenic Microbiology, School of Basic Medical Science China Medical University Shenyang China
8 shared publicationsJianqi Wu
Department of Neurosurgery, Shengjing Hospital of China Medical University, Shenyang, China
8 shared publicationsJing Liu
Department of Immunology, School of Basic Medical Science, China Medical University, Shenyang, China
6 shared publicationsSheng Zeng
Department of Immunology, School of Basic Medical Science, China Medical University, Shenyang, China
6 shared publicationsSong Bai
Department of Immunology, College of Basic Medical Sciences, China Medical University, Shenyang, Liaoning 110001, China
6 shared publications
Latest Publications
- Open Access
- 29 January 2024
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 15, 1353325
Traditional Chinese medicine Zhusha Anshen Wan: protective effects on liver, kidney, and intestine of the individual drugs using 1H NMR metabolomics
Introduction: Zhusha Anshen Wan (ZSASW) is a traditional Chinese medicine compound mainly composed of mineral drugs. In clinical practice, ZSASW did not show the toxicity of administering equal doses of cinnabar alone, suggesting that the four combination herbs in ZSASW can alleviate the damage of cinnabar. The effect of each herb on reducing the toxicity of cinnabar has not been fully explained.Methods: In our study, we utilized a metabonomics approach based on high-resolution 1H nuclear magnetic resonance spectroscopy to investigate the reduction of toxicity by each herb in ZSASW. Liver, kidney and intestinal histopathology examinations and biochemical analysis of the serum were also performed.Results: Partial least squares-discriminant analysis (PLS-DA) was conducted to distinct different metabolic profiles in the urine and serum from the rats. Liver and kidney histopathology examinations, as well as analysis of serum clinical chemistry analysis, were also carried out. The metabolic profiles of the urine and serum of the rats in the CGU (treated with cinnabar and Glycyrrhiza uralensis Fisch) and CCC (treated with cinnabar and Coptis chinensis French) groups were remarkably similar to those of the control group, while those of the CRG (treated with cinnabar and Rehmannia glutinosa Libosch) and CAS (treated with cinnabar and Angelica sinensis) groups were close to those of the cinnabar group. The metabolic profiles of the urine and serum of the rats in the CGU and CCC groups were remarkably similar to those of the control group, while those of the CRG and CAS groups were close to those of the cinnabar group. Changes in endogenous metabolites associated with toxicity were identified. Rehmannia glutinosa, Rhizoma Coptidis and Glycyrrhiza uralensis Fisch could maintain the dynamic balance of the intestinal flora. These results were also verified by liver, kidney and intestinal histopathology examinations and biochemical analysis of the serum. The results suggested thatDiscussion: The metabolic mechanism of single drug detoxification in compound prescriptions has been elucidated. Coptis chinensis and Glycyrrhiza uralensis serve as the primary detoxification agents within ZSASW for mitigating liver, kidney, and intestinal damage caused by cinnabar. Detoxification can be observed through changes in the levels of various endogenous metabolites and related metabolic pathways.
- 29 January 2024
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 15, 1353325
Open AccessTraditional Chinese medicine Zhusha Anshen Wan: protective effects on liver, kidney, and intestine of the individual drugs using 1H NMR metabolomics
Introduction: Zhusha Anshen Wan (ZSASW) is a traditional Chinese medicine compound mainly composed of mineral drugs. In clinical practice, ZSASW did not show the toxicity of administering equal doses of cinnabar alone, suggesting that the four combination herbs in ZSASW can alleviate the damage of cinnabar. The effect of each herb on reducing the toxicity of cinnabar has not been fully explained.Methods: In our study, we utilized a metabonomics approach based on high-resolution 1H nuclear magnetic resonance spectroscopy to investigate the reduction of toxicity by each herb in ZSASW. Liver, kidney and intestinal histopathology examinations and biochemical analysis of the serum were also performed.Results: Partial least squares-discriminant analysis (PLS-DA) was conducted to distinct different metabolic profiles in the urine and serum from the rats. Liver and kidney histopathology examinations, as well as analysis of serum clinical chemistry analysis, were also carried out. The metabolic profiles of the urine and serum of the rats in the CGU (treated with cinnabar and Glycyrrhiza uralensis Fisch) and CCC (treated with cinnabar and Coptis chinensis French) groups were remarkably similar to those of the control group, while those of the CRG (treated with cinnabar and Rehmannia glutinosa Libosch) and CAS (treated with cinnabar and Angelica sinensis) groups were close to those of the cinnabar group. The metabolic profiles of the urine and serum of the rats in the CGU and CCC groups were remarkably similar to those of the control group, while those of the CRG and CAS groups were close to those of the cinnabar group. Changes in endogenous metabolites associated with toxicity were identified. Rehmannia glutinosa, Rhizoma Coptidis and Glycyrrhiza uralensis Fisch could maintain the dynamic balance of the intestinal flora. These results were also verified by liver, kidney and intestinal histopathology examinations and biochemical analysis of the serum. The results suggested thatDiscussion: The metabolic mechanism of single drug detoxification in compound prescriptions has been elucidated. Coptis chinensis and Glycyrrhiza uralensis serve as the primary detoxification agents within ZSASW for mitigating liver, kidney, and intestinal damage caused by cinnabar. Detoxification can be observed through changes in the levels of various endogenous metabolites and related metabolic pathways.
- Open Access
- 10 December 2023
- Published by Wiley in Cancer Science
- Vol. 115 (2) , 334-346
Neuromedin U regulates the anti‐tumor activity of CD8+ T cells and glycolysis of tumor cells in the tumor microenvironment of pancreatic ductal adenocarcinoma in an NMUR1‐dependent manner
Pancreatic ductal adenocarcinoma (PDAC) is an aggressive cancer with a poor prognosis, which is lethal in approximately 90% of cases despite advanced standard therapies. A typical feature of PDAC is the immunosuppressive tumor microenvironment with multiple immunosuppressive factors including neurotransmitters. Recently, neuromedin U (NMU), a highly conserved neuropeptide with many physiological functions, has attracted attention for its roles in tumorigenesis and metastasis in several types of cancers. However, whether NMU affects PDAC progression remains unclear. In this study, using an orthotopic mouse model of PDAC in combination with bioinformatics analysis, we found that NMU was upregulated in tumor tissues from the patients with PDAC and positively correlated with a poor prognosis of the disease. Interestingly, knockout of the Nmu gene in mice enhanced the anti‐tumor functions of tumor‐infiltrating CD8+ T cells in an NMU receptor 1‐dependent manner. Additionally, NMU promoted the glycolytic metabolism of mouse PDAC tumors. The activities of pyruvate kinase (PK) and lactate dehydrogenase (LDH), pivotal enzymes involved in the regulation of lactate production, were markedly reduced in tumor tissues from NMU‐knockout mice. In vitro the presence of LDHA inhibitor can reduce the production of lactic acid stimulated by NMU, which can increase the anti‐tumor activity of CD8+ T cells. Moreover, treatment of the pancreatic cancer cells with a phosphoinositide 3‐kinase (PI3K) inhibitor diminished NMU‐induced lactate production and the activities of PK and LDH, suggesting that NMU might regulate glycolysis via the PI3K/AKT pathway.
- 10 December 2023
- Published by Wiley in Cancer Science
- Vol. 115 (2) , 334-346
Open AccessNeuromedin U regulates the anti‐tumor activity of CD8+ T cells and glycolysis of tumor cells in the tumor microenvironment of pancreatic ductal adenocarcinoma in an NMUR1‐dependent manner
Pancreatic ductal adenocarcinoma (PDAC) is an aggressive cancer with a poor prognosis, which is lethal in approximately 90% of cases despite advanced standard therapies. A typical feature of PDAC is the immunosuppressive tumor microenvironment with multiple immunosuppressive factors including neurotransmitters. Recently, neuromedin U (NMU), a highly conserved neuropeptide with many physiological functions, has attracted attention for its roles in tumorigenesis and metastasis in several types of cancers. However, whether NMU affects PDAC progression remains unclear. In this study, using an orthotopic mouse model of PDAC in combination with bioinformatics analysis, we found that NMU was upregulated in tumor tissues from the patients with PDAC and positively correlated with a poor prognosis of the disease. Interestingly, knockout of the Nmu gene in mice enhanced the anti‐tumor functions of tumor‐infiltrating CD8+ T cells in an NMU receptor 1‐dependent manner. Additionally, NMU promoted the glycolytic metabolism of mouse PDAC tumors. The activities of pyruvate kinase (PK) and lactate dehydrogenase (LDH), pivotal enzymes involved in the regulation of lactate production, were markedly reduced in tumor tissues from NMU‐knockout mice. In vitro the presence of LDHA inhibitor can reduce the production of lactic acid stimulated by NMU, which can increase the anti‐tumor activity of CD8+ T cells. Moreover, treatment of the pancreatic cancer cells with a phosphoinositide 3‐kinase (PI3K) inhibitor diminished NMU‐induced lactate production and the activities of PK and LDH, suggesting that NMU might regulate glycolysis via the PI3K/AKT pathway.
- 18 October 2023
- Published by Elsevier in International Immunopharmacology
- Vol. 124 (Pt B) , 111039
Gut Lactobacillus contribute to the progression of breast cancer by affecting the anti-tumor activities of immune cells in the TME of tumor-bearing mice
- 18 October 2023
- Published by Elsevier in International Immunopharmacology
- Vol. 124 (Pt B) , 111039
Gut Lactobacillus contribute to the progression of breast cancer by affecting the anti-tumor activities of immune cells in the TME of tumor-bearing mice
- 14 October 2022
- Published by Elsevier in International Immunopharmacology
- Vol. 113 (Pt A) , 109306
Group 2 innate lymphoid cells mediate the activation of CD4+ T cells and aggravate Th1/Th2 imbalance via MHC II molecules during respiratory syncytial virus infection
- 14 October 2022
- Published by Elsevier in International Immunopharmacology
- Vol. 113 (Pt A) , 109306
Group 2 innate lymphoid cells mediate the activation of CD4+ T cells and aggravate Th1/Th2 imbalance via MHC II molecules during respiratory syncytial virus infection
- Open Access
- 25 October 2021
- Published by Springer Nature in Research Square
Group 2 innate lymphoid cells mediate the activation of CD4+ T cells and aggravate Th1/Th2 imbalance via MHC II molecules during respiratory syncytial virus infection
Background Respiratory syncytial virus (RSV), as an important worldwide pediatric respiratory pathogen, can cause pneumonia and bronchiolitis in infants and young children. CD4+ T cells play a crucial role in RSV-induced airway inflammation. However, the underlying mechanism of CD4+ T cell activation during RSV infection is not fully understood. Methods The proliferation and activation of CD4+ T cells in the lungs of RSV infected BALB/c mice were measured by flow cytometry. RSV-induced airway inflammation was determined by HE staining and the inflammatory cells in bronchoalveolar lavage fluids (BALF) were counted. The protein levels of IL-4, IL-5, IL-13, and IFN-γ in the supernatant of BALF were detected by ELISA. The mRNA levels of IL-4, IL-5, IL-13, and IFN-γ in the lung homogenates were analyzed by real-time PCR. The expression of major histocompatibility complex II (MHCII), CD80 and CD86 on pulmonary ILC2s were measured by flow cytometry and real-time PCR. Results RSV infection may promote the differentiation and activation of CD4+ Th2 cells, resulting in imbalance of Th1/Th2 in the lung tissues. Depletion of CD4+ T cells can obviously reduce airway inflammation caused by RSV infection. Adoptive transfer of pulmonary ILC2s significantly enhanced the number of pulmonary CD4+ T cells and promoted their differentiation to Th2. In fact, RSV infection increased the expression of MHC II and B7 molecules on the surface of pulmonary ILC2s. In vitro co-culture experiments showed that ILC2s may act as a promoter to promote the expansion and differentiation of RSV-infected naïve CD4+ T cells. However, blocking the interaction between ILC2s and CD4+ T cells with anti-MHC II mAbs significantly reduced CD4+ T cell expansion and increased the Th1/Th2 ratio of CD4+ T cells. Conclusions Our data suggest that pulmonary ILC2s may function as antigen-presenting cells to induce the activation of CD4+ T cells through MHC II pathway during RSV infection.
- 25 October 2021
- Published by Springer Nature in Research Square
Open AccessGroup 2 innate lymphoid cells mediate the activation of CD4+ T cells and aggravate Th1/Th2 imbalance via MHC II molecules during respiratory syncytial virus infection
Background Respiratory syncytial virus (RSV), as an important worldwide pediatric respiratory pathogen, can cause pneumonia and bronchiolitis in infants and young children. CD4+ T cells play a crucial role in RSV-induced airway inflammation. However, the underlying mechanism of CD4+ T cell activation during RSV infection is not fully understood. Methods The proliferation and activation of CD4+ T cells in the lungs of RSV infected BALB/c mice were measured by flow cytometry. RSV-induced airway inflammation was determined by HE staining and the inflammatory cells in bronchoalveolar lavage fluids (BALF) were counted. The protein levels of IL-4, IL-5, IL-13, and IFN-γ in the supernatant of BALF were detected by ELISA. The mRNA levels of IL-4, IL-5, IL-13, and IFN-γ in the lung homogenates were analyzed by real-time PCR. The expression of major histocompatibility complex II (MHCII), CD80 and CD86 on pulmonary ILC2s were measured by flow cytometry and real-time PCR. Results RSV infection may promote the differentiation and activation of CD4+ Th2 cells, resulting in imbalance of Th1/Th2 in the lung tissues. Depletion of CD4+ T cells can obviously reduce airway inflammation caused by RSV infection. Adoptive transfer of pulmonary ILC2s significantly enhanced the number of pulmonary CD4+ T cells and promoted their differentiation to Th2. In fact, RSV infection increased the expression of MHC II and B7 molecules on the surface of pulmonary ILC2s. In vitro co-culture experiments showed that ILC2s may act as a promoter to promote the expansion and differentiation of RSV-infected naïve CD4+ T cells. However, blocking the interaction between ILC2s and CD4+ T cells with anti-MHC II mAbs significantly reduced CD4+ T cell expansion and increased the Th1/Th2 ratio of CD4+ T cells. Conclusions Our data suggest that pulmonary ILC2s may function as antigen-presenting cells to induce the activation of CD4+ T cells through MHC II pathway during RSV infection.
- Open Access
- 12 October 2021
- Published by Springer Nature in Research Square
Neuromedin U Induces Pulmonary Group 2 Innate Lymphoid Cell Activation via NMUR1 Pathway During Acute Respiratory Syncytial Virus Infection
Background:The activated group 2 innate lymphocytes (ILC2s) play a crucial role in respiratory syncytial virus (RSV)-induced airway inflammation by secreting large amount of type 2 cytokines. Although the classical activator IL-33 is the key factor for ILC2 activation, a regulatory effect of neurotransmitter-neuromedin U (NMU) has also been reported. However, whether and how NMU can be elicited by RSV infection and regulate pulmonary ILC2 activation remains unclear.Methods: The regulatory effect and underlying mechanisms of NMU on ILC2 activation were determined by using RSV-infected wild-type and NMU-knockout mice. The expression of NMU in the lungs and NMUR1 on ILC2s were measured by Real-time PCR and Western blot. Flow cytometry and ELISA were used to detect the proliferation and activation of ILC2s. The type of neurons secreting NMU and its possible secretion mechanism during RSV infection were also analyzed.Results:Acute RSV infection induced the production of NMU in the lungs of mice and up-regulate the expression of NMUR1 on the pulmonary ILC2s. In vivo administration of NMU exacerbated RSV-induced airway inflammation by promoting the proliferation and activation of pulmonary ILC2s via NMUR1 pathway. In this process, PI3K, MEK and NFAT signal proteins might be involved. Furthermore, pulmonary neurons responded to the stimulation of RSV and secreted NMU in TLR4 and TLR7-dependent manners.Conclusion:Our data suggest that NMU is an ILC2 activator other than the classical activator, revealing a novel effect of neurotransmitter on RSV-induced airway inflammation.
- 12 October 2021
- Published by Springer Nature in Research Square
Open AccessNeuromedin U Induces Pulmonary Group 2 Innate Lymphoid Cell Activation via NMUR1 Pathway During Acute Respiratory Syncytial Virus Infection
Background:The activated group 2 innate lymphocytes (ILC2s) play a crucial role in respiratory syncytial virus (RSV)-induced airway inflammation by secreting large amount of type 2 cytokines. Although the classical activator IL-33 is the key factor for ILC2 activation, a regulatory effect of neurotransmitter-neuromedin U (NMU) has also been reported. However, whether and how NMU can be elicited by RSV infection and regulate pulmonary ILC2 activation remains unclear.Methods: The regulatory effect and underlying mechanisms of NMU on ILC2 activation were determined by using RSV-infected wild-type and NMU-knockout mice. The expression of NMU in the lungs and NMUR1 on ILC2s were measured by Real-time PCR and Western blot. Flow cytometry and ELISA were used to detect the proliferation and activation of ILC2s. The type of neurons secreting NMU and its possible secretion mechanism during RSV infection were also analyzed.Results:Acute RSV infection induced the production of NMU in the lungs of mice and up-regulate the expression of NMUR1 on the pulmonary ILC2s. In vivo administration of NMU exacerbated RSV-induced airway inflammation by promoting the proliferation and activation of pulmonary ILC2s via NMUR1 pathway. In this process, PI3K, MEK and NFAT signal proteins might be involved. Furthermore, pulmonary neurons responded to the stimulation of RSV and secreted NMU in TLR4 and TLR7-dependent manners.Conclusion:Our data suggest that NMU is an ILC2 activator other than the classical activator, revealing a novel effect of neurotransmitter on RSV-induced airway inflammation.
- 1 October 2021
- Published by Elsevier in International Immunopharmacology
- Vol. 99, 107924
Group 2 innate lymphoid cells promote TNBC lung metastasis via the IL-13-MDSC axis in a murine tumor model
- 1 October 2021
- Published by Elsevier in International Immunopharmacology
- Vol. 99, 107924
Group 2 innate lymphoid cells promote TNBC lung metastasis via the IL-13-MDSC axis in a murine tumor model
- Open Access
- 12 August 2021
- Published by Taylor & Francis in Virulence
- Vol. 12 (1) , 2133-2148
Oral administration of Clostridium butyricum rescues streptomycin-exacerbated respiratory syncytial virus-induced lung inflammation in mice
Changes in the intestinal microbiota indirectly impact the health of mucosa distal to the intestine, particularly the respiratory tract. However, the effects of intestinal microbiota dysbiosis on the regulation of respiratory syncytial virus (RSV) infection are not clear. In this study, we examined the effects of altering the intestinal microbiota on the pulmonary immune response against RSV infection. BALB/c mice were treated with streptomycin before infection with RSV to study the altered immune response. The ingestion of streptomycin led to a marked alteration in the intestinal microbiota with a reduced abundance of Lactobacillus and Clostridium genera, followed by greatly aggravated pulmonary inflammation in response to RSV infection. This aggravated inflammation was associated with a dysregulated immune response against RSV infection, characterized by the increased expression of IFN-γ and IL-17 and increased pulmonary M1-like macrophage polarization, and decreased expression of IL-5. Supplementation of Clostridium butyricum (CB) prevented aggravated inflammation and the dysregulated immune response characterized by greater M2 polarization of pulmonary macrophages and decreased release of IFN-γ and IL-17 as well as increased IL-5 levels. Furthermore, in vitro and in vivo experiments identified that butyrate, the main metabolite produced by CB, promoted M2 polarization of macrophages in RSV-infected mice exposed to streptomycin. Together, these results demonstrate the mechanism by which intestinal microbiota modulate the pulmonary immune response to RSV infection.
- 12 August 2021
- Published by Taylor & Francis in Virulence
- Vol. 12 (1) , 2133-2148
Open AccessOral administration of Clostridium butyricum rescues streptomycin-exacerbated respiratory syncytial virus-induced lung inflammation in mice
Changes in the intestinal microbiota indirectly impact the health of mucosa distal to the intestine, particularly the respiratory tract. However, the effects of intestinal microbiota dysbiosis on the regulation of respiratory syncytial virus (RSV) infection are not clear. In this study, we examined the effects of altering the intestinal microbiota on the pulmonary immune response against RSV infection. BALB/c mice were treated with streptomycin before infection with RSV to study the altered immune response. The ingestion of streptomycin led to a marked alteration in the intestinal microbiota with a reduced abundance of Lactobacillus and Clostridium genera, followed by greatly aggravated pulmonary inflammation in response to RSV infection. This aggravated inflammation was associated with a dysregulated immune response against RSV infection, characterized by the increased expression of IFN-γ and IL-17 and increased pulmonary M1-like macrophage polarization, and decreased expression of IL-5. Supplementation of Clostridium butyricum (CB) prevented aggravated inflammation and the dysregulated immune response characterized by greater M2 polarization of pulmonary macrophages and decreased release of IFN-γ and IL-17 as well as increased IL-5 levels. Furthermore, in vitro and in vivo experiments identified that butyrate, the main metabolite produced by CB, promoted M2 polarization of macrophages in RSV-infected mice exposed to streptomycin. Together, these results demonstrate the mechanism by which intestinal microbiota modulate the pulmonary immune response to RSV infection.